Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
19.07
-0.22 (-1.12%)
Mar 31, 2025, 10:05 AM EDT - Market open
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,650 employees as of December 31, 2024. The number of employees increased by 250 or 10.42% compared to the previous year.
Employees
2,650
Change (1Y)
250
Growth (1Y)
10.42%
Revenue / Employee
$354,794
Profits / Employee
-$36,236
Market Cap
1.27B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TNDM News
- 12 days ago - Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes - Business Wire
- 12 days ago - Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States - Business Wire
- 4 weeks ago - Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism - Seeking Alpha
- 4 weeks ago - Tandem Diabetes Care, Inc. (TNDM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance - Business Wire
- 4 weeks ago - Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes - Business Wire
- 6 weeks ago - Tandem Diabetes Care Announces Upcoming Conference Presentations - Business Wire
- 2 months ago - Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire